They reduce your risk for cardiovascular disease [and] they reduce your risk for kidney disease if you have obesity or diabetes
Regardless of whether you are taking this medication for blood glucose or weight management, the following quote by the Swiss Physician, Paracelsus, in 1538 also applies to GLP-1s
[1] The American Diabetes Association (ADA) primarily recommends B12 monitoring for patients on long-term metformin therapy rather than for those on GLP-1/GIP receptor agonists
Annals of Neurology 39, 385-389CrossRefGoogle ScholarPubMed 167Tabrizi, S.J., Workman, J., Hart, P.E
Table 10.2 Effects of metformin against insulin resistance syndrome Initial doses (500 mg once a day) must be slowly increased at weekly intervals and administered two or three times a day before or together with meals considering a maximum dose of 2,550 mg/day